Active Psychiatric Research Studies
ALPHABETICAL
LISTING OF RESEARCH ACTIVITIES BY INVESTIGATOR
A | B | C | D | E | F | G | H |
I |J | K | L |M | N | O | P |
Q | R | S |T
|U | V |W | X|
Y |
Z |
| ---Go To The Bottom of Page---|
A
Lisa M. Amaya-Jackson
(Child & Adolescent Psych)
Child Medical Evaluation Program
University of North Carolina-Chapel Hill
Family Functioning In Stressed And Maltreating Families
University of North Carolina-Chapel Hill
Adrian
C. Angold (Child & Adolescent Psych)
Assessing
Preschool Comorbidity: A Test-Retest Study
National Institutes of Health
A | B | C | D | E | F | G | H |
I |J | K | L |M | N | O | P |
Q | R | S |T
|U | V |W | X|
Y |
Z |
Select Another Letter from A to Z For Other Research Information or Return to MAIN Index Page
| ---Go To The Bottom of Page---|---Go To The Top of Page -------|
B
John
A. Barefoot (Medical Psychology)
Hostility Depression Social Environment and CHD Risk
National Institutes of Health
Jean
C. Beckham (Medical Psychology)
Assessment Of Hostility And Health In Veterans With PTSD
National Institutes of Health
Smoking & Anxiety In Posttraumatic Stress Disorder
National Institutes of Health
James
Blumenthal (Behavioral Psychiatry)
Stress & Myocardial Ischemia: Mechanisms & Treatment
National Institutes of Health
Exercise Training And Depression In Older Adults
National Institutes of Health
Behavioral Treatment Of Fibromyalgia
University of Ohio
Behavioral Treatment of Hypertension
National Institutes of Health
Enhancing Recovery in Coronary Heart Disease (ENRICHED)
National Institutes of Health
ENRICHED Ancillary Study: HRV and Low Social Support
Dana Foundation
Depression and Mortality Following Myocardial Infarction
Washington University
Randy
Borum (Medical Psychology)
Criminal Justice Diversion Initiative for Individuals with Co-Occurring Mental
Illness and Substance Abuse Disorders. Coordinating Center for Multi-Site Study
Research Triangle Institute
Hayden
Bosworth (Medical Psychology)
Take Control of Your Blood Pressure (TCYB) Study
National Heart, Lung & Blood Institute
Study to Lower Veterans' Blood Pressure: Patient/Physician Intervention
Veterans Affairs HSR&D
Nurse Administered Tailored Self-Management Intervention for Functionally
Illiterate Adults to Improve Blood Pressure Control
Pfizer Foundation
Lisa
Brauer (Biological Psychiatry)
Dopaminergic Mechanisms Of Nicotine Addiction
National Institutes of Health
Phentermine and Nicotine for Smoking Cessation
National Institutes of Health
Craving for Cigarettes: Nicotine, Smoking and Stress
National Institutes of Health
John
Breitner (Geriatrics)
Head Injury and Alzheimer's Disease
NIA
Genetic Epidemiology of Alzheimer Disease in Twins
National Institute of Health
Co-Twin Control Study of Alzheimer's Disease
American Health Association
Barbara
J. Burns (Social & Community Psych)
Therapeutic Foster Care in a System Of Care
Case Western Reserve University
Home and Community-Based Mental Health Services Research
Medical University of South Carolina
Mental Health Service Across Child Welfare Agencies
Case Western
A |
B | C | D | E | F | G | H |
I |J | K | L |M | N | O | P |
Q | R | S |T
|U | V |W | X|
Y |
Z |
Select Another Letter from A to Z For Other Research Information or Return to MAIN Index Page
| ---Go To The Bottom of Page---|---Go To The Top of Page -------|
C
Frederick
Cassidy (Biological Psychiatry)
A Follow-up Study of Patients Completing Protocol #CNS-1879-001, A
Placebo-Controlled Study in Depressed Inpatients Undergoing
Electroconvulsive Therapy
CATO
Noradrenergic Mechanism of ECT in the Treatment of Depression
DUMC Small Research Grant
Subtypes of Manic States: External Validation with Adenylyl Cyclase
National Alliance for Research on Schizophrenia & Depression
Sheila
Collins (Biological Psychiatry)
Mechanisms Regulating Expression Of The Ucp2 Gene
National Institutes of Health
Steroid Regulation of B-adrenoreceptor Genes in Obesity
National Institutes of Health
Sequalae of Chronic B3-agonist Exposure in Dogs: BAT Up-regulation and
Desensitization of Cardiovascular and Metabolic Responses
Merck Research Laboratories
Steroid Regulation of B-Adrenoreceptor Genes in Obesity
National Institutes of Health
B3-Adrenergic Receptors and MAP Kinase Signaling
American Diabetes Association
Transcription And Function Of Adipocyte B3AR In Obesity
National Institutes of Health
Carmen
K. Conners (Medical Psychology)
Long Term Open-Label Safety and Treatment Study of Children Who Relapse
Following Discontinuation Meds
Eli Lilly Corporation
A randomized Double-Blind Study of in Pediatric Outpatients with ADHD
Eli Lilly & Co.
A Multi-center, Open-Label, Uncontrolled, Dose in the Treatment of Attention Deficit/Hyperactivity in Children
with ADHD
GlaxoWellcome
Multimodal Treatment Study Of Children With ADHD
National Institutes of Health
A Double-blind, Randomized, Parallel-Design, Placebo-Controlled Trial in
Children with Attention Deficit Disorder
Celgene Corporation
A Six-month Open-Label Safety Trial Children with Symptoms of Attention Deficit Hyperactivity Disorder
Celgene Corporation
Double-Blind, Variable Randomized and Discontinuation Study in Children with
ADHD who Meet Response Criteria During
Eli Lilly Corporation
Multicenter Study Comparing the Efficacy and Safety in Children with ADHD
Alza Corporation and Ppd Inc.
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group,
Dose-Ranging Study of in the Treatment of Attention
Deficit/Hyperactivity
GlaxoWellcome
An Open-Label, Long Term, Flexible Dose Safety Study of Treatment Of Childhood Attention Deficit Hyperactivity Disorder
Bristol-Myers Squibb
Developmental Neuropsychology Of ADHD
National Institutes of Health
A Double-Blind, Placebo-Controlled Study in Children with ADHD
Medeva Americas, Inc
A Preliminary, Multi-center, Randomized Double-Blind Controlled Evaluation Adult Patients with ADHD
Eisai America Inc.
Elizabeth
Costello (Child & Adolescent Psych)
Prepubertal Comorbidity: Gender and Development Heterotypy
National Institute of Mental Health
Growing Up Violent in Rural America
National Institute of Mental Health
Multi-Site Longitudinal Analysis of Psychiatric Risk of SUD
National Institute on Drug Abuse
Vulnerability
to Drug Abuse: A Test of Competing Models
National Institute on Drug Abuse
Adolescence to Adulthood: Resilience to Poverty in American Indian and Anglo
Youth in Rural America
William T Grant Foundation
Applying Developmental Epidemiology to Youth Services
National Institutes of Health
A | B | C | D | E | F | G | H |
I |J | K | L |M | N | O | P |
Q | R | S |T
|U | V |W | X|
Y |
Z |
Select Another Letter from A to Z For Other Research Information or Return to MAIN Index Page
| ---Go To The Bottom of Page---|---Go To The Top of Page -------|
D
Jonathan
Davidson (Outpatient Psychiatry)
Protocol 107 - A Multi-center, Randomized, Double-Blind, Parallel-Group, Placebo
Controlled, Dose-Range Finding Trial with Social Phobia
Novartis Pharmaceuticals Corporation
Treatment of Generalized Anxiety Disorder
Madis Botanicals Inc.
Family Study of Chronic Post-Traumatic Stress Disorder
National Institutes of Health
Maintenance in Posttraumatic Stress Disorder
National Institutes of Health
Treatment of Obsessive Compulsive Disorder (OCD)
Roche
Prevalence and Health Utilization of PTSD in Primary Care
Pfizer Pharmaceuticals
Discontinuation Study in Social Phobia
Hoffman-LaRoche
Depressive Disorder
National Institutes of Health
Study of Treatment in Major Depressive Disorders
Pharmacia & UpJohn Inc.
A Placebo-Controlled Trial In Social Phobia
Parke-Davis Pharmaceutical Company
Treatment of Post Traumatic Stress
Disorder: Protocol F1D-MC-X055
Eli Lilly Corporation
Social Phobia With Substance Abuse
SmithKline Beecham Pharmaceuticals
In The Treatment Of Social
Phobia
Bristol-Myers Squibb
Treatment Of Post-Traumatic Stress Disorder
GlaxoWellcome
Patches in the Treatment Of Anxious Outpatients
Bristol-Myers Squibb
Behavior Therapy In Social Phobia
National Institutes of Health
Treatment of Generalized Social Phobia
Smith Klein Beecham
Graduate Medical Training Fellowship: Psychiatric Clinical Research and Drug
Development
GlaxoWellcome
PTSD
Outpatients
Pfizer
Social Phobia
Warner-Lambert Co
Solvay
Consumer Contact with the ADAA
Anxiety Disorder
Treatment of Post-Traumatic Stress
Disorder
Bristol Myers Squibb
Social Phobia
Lilly
Treatment of
Outpatients with MDD
Merck & Co
Patients with Moderate to Severe Major Depressive Disorder
Novartis Pharmaceuticals Corporation
Murali
Doraiswamy (Biological Psychiatry)
Alzheimer's Disease In the Community Setting
Novartis Pharmaceuticals Corporation
lzheimer's Disease
Merck & Company Inc.
Major Depressive Disorder
National Institutes of Health
Major Depression
Eli Lilly Corporation
Quality of Life In Elderly Medical Patients During Antidepressant Therapy
GlaxoWellcome
Sandoz Educational Fund
Sandoz Pharmeuticals Corporation
Cerebral Blood Flow Measurement In Late Life Depression Us
National Alliance For Research On Schizophrenia & Depression
Apolipoprotein E Type 4 Allele And Cerebral Metabolism in Relatives at Risk for
Alzheimer's Disease
American Federation for Aging Research
Treatment of Major Depression
Eli Lilly & Co
Major Depression
Eli Lilly & Co
Magnetic Resonance Markers of Degeneration in Alzheimer's Disease
Bayer Corporation
Cerebral Blood Flow Measurements in Late-Life Depression Using MRI
National Alliance for Research on Schizophrenia & Depression
Neuroimaging In HIV Infection
University of North Carolina-Chapel Hill
Lawrence
Dunn (Biological Psychiatry)
On Health Outcomes with Schizophrenia
and Schizoaffective Disorders
Zeneca Inc.
A | B | C | D | E | F | G | H |
I |J | K | L |M | N | O | P |
Q | R | S |T
|U | V |W | X|
Y |
Z |
Select Another Letter from A to Z For Other Research Information or Return to MAIN Index
Page
| ---Go To The Bottom of Page---|---Go To The Top of Page -------|
E
Jack
D. Edinger (Medical Psychology)
Dose Response Effects Of Behavioral Insomnia Therapies
National Institutes of Health
Cognitive-Behavioral Therapy for Primary Insomnia
National Institutes of Health
Christopher
Edwards (Medical Psychology)
The Relationship Between Depression and Glycemic Control in Type I and Type II -
Post-Doc Fellow
National Alliance for Research on Schizophrenia & Depression
Helen
Egger (Child & Adolescent Psych)
Developmental Epidemiology of Anxiety in Preschoolers
National Institute of Mental Health
Developmental Epidemiology of Preschool Psychopathology
Pfizer, Inc.
Everett
H. Ellinwood (Biological Psychiatry)
Presynaptic Dopamine Mechanisms After Chronic Cocaine
National Institutes of Health
Parameters of Treatment Dosing
University of California - San Francisco
Evaluation of Xeno-graft Transplantation Neurotrophic Therapy & Gene Therapy
in Hydroxydopamine Model in Parkinson's Disease
Novartis Pharmaceuticals Corporation
Jeff
Epstein (Medical Psychology)
Neuropsychological Functioning in Adults with ADHD
DUMC Small Research Grant
Neuropsychological Functioning in Adults with ADHD
National Institutes of Health
Alaattin
Erkanli (Child & Adolescent Psych)
Validity Without a Gold Standard
National Institute of Mental Health
Charles
Erwin (Biological Psychiatry)
Adult Patients with Insomnia
Wyeth-Ayerst Research
Evaluate
Residual Sedation ater Nocturnal Awakening in Patients with Sleep
Maintenance Insomnia
Wyeth-Ayerst Research
A | B | C | D | E | F | G | H |
I |J | K | L |M | N | O | P |
Q | R | S |T
|U | V |W | X|
Y |
Z |
Select Another Letter from A to Z For Other Research Information or Return to MAIN Index Page
| ---Go To The Bottom of Page---|---Go To The Top of Page -------|
F
John
A. Fairbank (Medical Psychology)
Relationships of Stress Exposures To Health In Gulf War Veterans
Army
Socioeconomic Consequences of Traumatic Stress
Research Triangle Inst.
Leslie
M. Forman (Outpatient Psychiatry)
Treatment of Elderly Subjects Residing in
Nursing Homes or Assisted Care Facilities and Presenting with Alzheimer's
Dementia and Psychoses or Other Selected Psychoses
Zeneca Inc.
The Management Of Behavioral Disturbances and/or Psychosis in
Demented Nursing Home Patients
Eli Lilly Corporation
Management of Patients with Alzheimer's Disease
in a Nursing Home Facility
Eisai America Inc.
Major
Depression After Myocardial Infarction (Sadhart)
Pfizer
A | B | C | D | E | F | G | H |
I |J | K | L |M | N | O | P |
Q | R | S |T
|U | V |W | X|
Y |
Z |
Select Another Letter from A to Z For Other Research Information or Return to MAIN Index Page
| ---Go To The Bottom of Page---|---Go To The Top of Page -------|
G
Kishore
M. Gadde (General Psychiatry)
Obesity
GlaxoWellcome
Major Depression
National Alliance for Research on Schizophrenia & Depression
Jeffrey
Georgi (Biological Psychiatry)
Family Care Program
Durham County Mental Health
Veeraindar
Goli (Biological Psychiatry)
Chronic Pain
Knoll Pharmaceutical
Knoll Pharmaceutical
Pain Associated with Diabetic Neuropathy
Wyeth-Ayerst
A | B | C | D | E | F | G | H |
I |J | K | L |M | N | O | P |
Q | R | S |T
|U | V |W | X|
Y |
Z |
Select Another Letter from A to Z For Other Research Information or Return to MAIN Index Page
| ---Go To The Bottom of Page---|---Go To The Top of Page -------|
H, I,
J
Diane Johnson (Medical Psychology)
Children with
Symptoms of Attention Deficit Hyperactivity Disorder
Celgene Corporation
A | B | C | D | E | F | G | H |
I |J | K | L |M | N | O | P |
Q | R | S |T
|U | V |W | X|
Y |
Z | Select Another Letter from A to Z For Other Research Information or Return to MAIN Index Page
| ---Go To The Bottom of Page---|---Go To The Top of Page -------|
K
Francis
Keefe (Medical Psychology)
Cognitive Behavioral Treatments for Arthritis Pain
NIAR
Coping with Osteoarthritic Knee Pain
NIAR
Behavioral Treatment of Fibromyalgia
National Institutes of Health
Enhancing Recovery in Coronary Heart Disease (ENRICHED)
University of North Carolina - Chapel Hill
Richard
Keefe (Medical Psychology)
Working Memory Deficits and Prefrontal Dysfunction in Schizophrenia
National Alliance for Research on Schizophrenia & Depression
Neural Circuitry And Cognitive Function In Schizophrenia
National Institutes of Health
Psychotic Symptom Reduction
Janssen Pharmaceutical
Harold
G. Koenig (Geriatric Psychiatry)
Study the Effects of Religion/Spirituality on use of Health Services by a Group
of High Utilizers
Mary Duke Biddle Foundation
Impact Of Religion And Spirituality On Health Service Use
Arthur Vining Davis
Impact Of Religion And Spirituality On Health Service Use
Fetzer Institute
Impact Of Religion & Spirituality On Health Service Use
Sir John Templeton Foundation
Depressive Disorder in Hospitalized Medically Ill Elders
National Institutes of Health
Measuring Religious Coping: A Follow-up Study
Bowling Green State
Deborah
Koltai (Medical Psychology)
A Perspective Cohort Study Of Estuary-Associated Syndrome in Coastal North
Carolina
University of North Carolina-Chapel Hill
Ranga
R. Krishnan (Affective Disorders)
Treatment of Elderly Outpatients With Major Depression
Pfizer Pharmaceuticals
Sandoz Pharmeuticals Corporation
Brief Cognitive Screen - Caregiver Version
Pfizer Pharmaceuticals
Alzheimer's Disease
International Clinical Research Corp
Relationship of MRI Hyperintensities to Treatment Response in Geriatric
Depression
Rhode Island Hospital
Depressed
Patient at Least 75 Years of Age
Forest Laboratories NY
Bipolar Disorder in Late Life
National Institutes of Health
Patients with Dementia Associated with Cerebrovascular Disease
Eisai America Inc.
Genetic Imaging Study In Bipolar Disorder
National Alliance For Research On Schizophrenia & Depression
Alzheimer's Disease -- Antemortem Markers
National Institutes of Health
The Treatment Of
Behavioral Manifestations of Alzheimer's Disease in Outpatients
Pfizer Pharmaceuticals
Patients with Alzheimer's Disease
Eisai America Inc.
Depression In Elderly Cardiac Patients
National Institutes of Health
Pfizer Pharmaceuticals
Time to Diagnosis of Probable Alzheimer's
Disease in At-Risk Subjects -- Data Management and Analysis Center
Novartis Pharmaceuticals Corporation
CRC Study of Depression
National Institutes of Health
Depression in Nursing Placement of Alzheimer's Disease (AD) Patients
Battelle Memorial Institute
Forest Laboratories, Inc
Depression in Late Life
National Institutes of Health
Cortisol Cognition Brain Atrophy and Depression
National Institutes of Health
Depression in Elderly Cardiac Patients
National Institutes of Health
Patients with Probable Mild to Moderate
Alzheimer's Disease
Novartis
Patients with Probable Mild to Moderate
Alzheimer's Disease
Sandoz
Andrew
D. Krystal (Outpatient Psychiatry)
Improving ECT Effectiveness Through ICTAL EEG Analysis
National Institutes of Health
Magnetic Resonance Spectroscopic and Electrophysiologic Correlates of Major
Depression and its Response to Electroconvulsive Therapy
National Alliance For Research On Schizophrenia & Depression
A Multicenter, Randomized, Double-Blind, Three-Period Crossover Study to
Evaluate Residual Sedation after a Nocturnal Awakening in Patients with Sleep
Maintenance Insomnia
Wyeth-Ayerst Research Inc.
Optimizing ECT Stimulus Dosing Using the ICTAL EEG
National Institutes of Health
A | B | C | D | E | F | G | H |
I |J | K | L |M | N | O | P |
Q | R | S |T
|U | V |W | X|
Y |
Z |
Select Another Letter from A to Z For Other Research Information or Return to MAIN Index
Page
| ---Go To The Bottom of Page---|---Go To The Top of Page -------|
L
James
Lane (Medical Psychology)
Caffeine Effects on Stress Reactivity
National Institutes of Health
Caffeine Effects on Stress Reactivity - Minority Supplement
National Institutes of Health
Tong
H. Lee (Biological Psychiatry)
Dopamine Presynaptic Inhibition and Cocaine Pretreatment
DUMC Small Research Grts
Dopamine Presynaptic Inhibition and Cocaine Treatment
National Institutes of Health
Edward
D. Levin (Biological Psychiatry)
Proposal For Renewing Rjr-Leon Golberg Memorial Fellowship
R. J. Reynolds Industries
Chronic Nicotine-Infusion Induced Memory Improvement
National Institutes of Health
Integrated Toxicology Training Program
National Institutes of Health
Cognitive Aspects Of Nicotinic Interactions With Atypical Antipsychotics
National Alliance for Research on Schizophrenia & Depression
Neurotoxic Effects of Adult and Developmental Exposure to Pfiesteria Toxin
Environmental Protection Agency
Collaborative Research Training in Environmental Toxicology
Environmental Protection Agency
Symposium: Attention as a Target of Intoxication: Insights and Methods from
Studies of Drug Abuse
National Institutes of Health
Isaac
Lipkus (Medical Psychology)
Using Tailored Messages to Improve Colroctal Screening
AMC Cancer Center
Recruiting Teen Smokers Into A Self-Help Quit Smoking Program
National Institutes of Health
Mammography Screening Among African-American Women with a Family History of
Breast Cancer
Army
Thomas
Lynch (Biological Psychiatry)
Dialectical Behavior Therapy for Depressed Older Adults
National Institutes of Health
A Comparison Between Dialectical Behavior Skills, Group Cognitive Therapy, and
Pharmacotherapy in the Treatment of Depression Among Older Adults
Duke Small Research Grt.
Using Magnetic Resonance Imaging to Examine Conditioning Salicncc and
Habituation to Emotional Stimuli in Depression
National Alliance for Research on Schizophrenia & Depression
A | B | C | D | E | F | G | H |
I |J | K | L |M | N | O | P |
Q | R | S |T
|U | V |W | X|
Y |
Z |
Select Another Letter from A to Z For Other Research Information or Return to MAIN Index Page
| ---Go To The Bottom of Page---|---Go To The Top of Page -------|
M
John
S. March (Child & Adolescent Psych)
Research In Pediatric Anxiety Disorders
National Institutes of Health
Treatment Of Pediatric Obsessive-Compulsive Disorder
National Institutes of Health
Multi-modal Trauma Treatment In Hamlet
National Institutes of Health
Effectiveness of Treatment for Adolescents with Major Depression
National Institutes of Health
Study of Children and Adolescents with PTSD
Solvay Pharmaceutical
Adolescent Social Phobia Research Fund
Pfizer
Children and Adolescents (Aged 6 to 17)
with GAD
Bristol-Myers Squibb
Roy
J. Mathew (Biological Psychiatry)
Marijuana Intoxication and Brain Activation
National Institutes of Health
Joseph
P. McEvoy (Biological Psychiatry)
Abbott Laboratories
Antipsychotic Activity Hospitalized Schizophrenic Patients
Merck & Company Inc.
Therapy to Mood Stabilizers in the Treatment of the Manic Phase of Bipolar
Disorder
Janssen Pharmaceuticals
Treatment of Schizophrenia
Pharmacia/Upjohn
Schizophrenic Patients
Sanofi Winthrop Pharmaceuticals
Cognition in Schizophrenia
Alza Corporation and Ppd Inc.
Smoking and Bipolar I Disorder
National Alliance for Research on Schizophrenia & Depression
Schizophrenic Patients
Sanofi Winthrop Pharmaceuticals
Allelic Variation in Schizophrenia (FID-MC-HGGL(a))
Innovex
An Open Extension Study Evaluating
Hoechst Marion Roussel Inc.
Schizophrenia and
Schizoaffective Disorder Study #245-102-5009
Pfizer Pharmaceuticals
Schizophrenic and Schizoaffective Patients
Hoechst Marion Roussel Inc.
Schizophrenic and Schizoaffective Patients
Hoechst Marion Roussel Inc.
The Treatment Of Bipolar Disorder, Manic or Mixed
Eli Lilly Corporation
The Treatment Of Acutely
Maniac Patients with Bipolar Disorder
Abbott Laboratories
In First-Episode Psychotic
Disorders
Eli Lilly Corporation
Schizophrenia and
Schizoaffective Disorder
Janssen Pharmaceuticals
In Chronic Schizophrenia and the Companion
Study: Open-Label Study of Olanzapine Treatment
Eli Lilly Corporation
Treatment of an
Acute Manic Episode in Patients with Bipolar Disorder
GlaxoWellcome
Subjects with Mania
Pfizer Pharmaceuticals
Smoking Schizophrenia and Atypical Anti-psychotics
Janssen Pharmaceuticals
Treatment of Schizophrenia - RIS USA-113
Janssen Pharmaceuticals
In
Patients with Psychosis
Berger-Boyer & Associates Inc.
Contract Agreement: Smoking, Schizophrenia and Atypical Antipsychotics
Janssen Research
Scott
D. Moore (Biological Psychiatry)
Ethanol Actions in the Amygdala in Vitro Preparation
National Institutes of Health
A | B | C | D | E | F | G | H |
I |J | K | L |M | N | O | P |
Q | R | S |T
|U | V |W | X|
Y |
Z |
Select Another Letter from A to Z For Other Research Information or Return to MAIN Index
Page
| ---Go To The Bottom of Page---|---Go To The Top of Page -------|
N
Paul
Nagy (Child & Adolescent Psych)
Goldstein Grant
National Institutes of Health
Substance Abuse/Mental Health/HIV/AIDS Cost Study (SAMHHACS)
National Institutes of Health
Melissa
A. Napolitano (Psychiatry)
Psychological Intervention For Patients Awaiting Lung Transplantation
American Lung Association
A |
B | C | D | E | F | G | H |
I |J | K | L |M | N | O | P |
Q | R | S |T
|U | V |W | X|
Y |
Z |
Select Another Letter from A to Z For Other Research Information or Return to MAIN Index Page
| ---Go To The Bottom of Page---|---Go To The Top of Page -------|
O,
P, Q
Select Another Letter from A to Z For Other Research Information or Return to MAIN Index Page
| ---Go To The Bottom of Page---|---Go To The Top of Page -------|
R
Jed
E. Rose (Biological Psychiatry)
Neuro-imaging Techniques For The Analysis Of Nicotine Addiction
Charles A. Dana Foundation
Smoking
Cessation
American Cancer Society
Nicotine Tolerance and Blockade in Cigarette Smokers
National Institutes of Health
Nicotinic Influences on Alcohol Use and Dependence
National Institutes of Health
A | B | C | D | E | F | G | H |
I |J | K | L |M | N | O | P |
Q | R | S |T
|U | V |W | X|
Y |
Z | Select Another Letter from A to Z For Other Research Information or Return to MAIN Index Page
| ---Go To The Bottom of Page---|---Go To The Top of Page -------|
S
Susan
S. Schiffman (Medical Psychology)
Gustatory and Olfactory changes with Age
National Institutes of Health
A Taste Perception Evaluation in Adult
Asthma Patients
Forest Laboratories NY
Orange Sodas & Colas: Factors that Influence Volume Consumed
Pepsi
Medications Effect on Taste and Smell in HIV
National Institutes of Health
Human Sensory Evaluations
Nutra Sweet Co
Use of Electronic Nose to Characterize Microorganisms in Heating/Air
Conditioning Systems
Center for Indoor Air
Taste Perception of Antibiotic Formulations
TAP Holdings, Inc
Andrew
Sherwood (Medical Psychology)
Menopausal Effects In Cardiovascular Stress Responses
National Institutes of Health
Biobehavioral Mechanisms of Blood Pressure Regulation
National Institutes of Health
Ilene
C. Siegler (Medical Psychology)
Surveillance And Analysis Of The UNC Alumni Heart Study
National Institutes of Health
Improving Cancer Risk Communication
National Institutes of Health
Models of Personality, Health and Disease in Adulthood
National Institutes of Health
Anna
Stout (Medical Psychology)
Premenstrual Dysphoric Disorder
Pfizer
David
C. Steffens (General Psychiatry)
Geriatric Depression: Apoliporotein E And Dementia Risk
National Institutes of Health
Geriatric Depression:
Risk Factors for Adverse Outcome
National Institute of Health
Neuroendocrine Regulation in Depression
National Institutes of Health
Edward
C. Suarez (Medical Psychology)
Hostility & CHD:SNS Lipid & Cell Molecular Mechanisms
National Institutes of Health
Richard
S. Surwit (Behavioral Psychiatry)
Effects of PPAR Ligands on Obesity & Insulin Sensitivity in Fat-fed B6 Mice
Merck & Company Inc.
Medical Center Community Partnership For Clinical Trials in Obesity
Robert Wood Johnson Foundation
Relationship of Depression to Glycemic Control in the Kaiser NC Patient
Population
Pfizer Pharmaceuticals
Investigation of SUR1 Agonists in Treatment of Diabetes and Obesity
GlaxoWellcome
Jeffrey
W. Swanson (Social & Community Psychiatry)
Schizophrenia Care and Assessment Program – Assessing the
cost effectiveness of new treatments for schizophrenia in six systems
of care and implementing a standardized instrument for monitoring
outcomes in schizophrenia care.
Eli
Lilly and Company / The MEDSTAT Group
|